In ITGA6–WFL, the signal‐to‐background levels were lower than in other ITGA6 assays, which suggests that ITGA6 glycovariants with a GalNAc–glycan structure are not common in HNSCC tumor tissue. This evidence concerns the gene ITGA6 and neoplasm.